{
  "@context": "https://orbyd.app/schemas/dossier.v1.json",
  "ticker": "OXM",
  "name": "Oxford Industries, Inc.",
  "url": "https://orbyd.app/dossiers/OXM/",
  "json_url": "https://orbyd.app/dossiers/OXM.json",
  "status": "DORMANT",
  "current_conviction": "MEDIUM",
  "graded_conviction": "LOW",
  "archetype": {
    "code": "a4",
    "n": 4
  },
  "current_thesis": "Setup inverted since the June breakdown. OXM reclaimed its 200-day ($39.11) and 50-day ($39.94) off the $35.83 low, the CEO bought 2,500 shares at $36.90 on 2026-06-12, and ~$25M of filed IEEPA tariff-refund claims — 4% of market cap, excluded from guidance — is landing as cash into a 20.7% short float. A special-situation cash-recovery leg, not an accelerating consumer narrative.",
  "invalidation_trigger": "A weekly close below $38 breaks the July base, puts the 200-day ($39.11) back overhead and turns the reclaim into a failed bounce. Secondary: Phase 2 IEEPA refund process not established by the September Q2 call, or a dividend cut, removes the quantified catalyst.",
  "catalyst_date": null,
  "outcome": "PLAYED_OUT",
  "outcome_date": "2026-07-09",
  "invalidation_fired": false,
  "themes": [
    "consumer-discretionary-rotation"
  ],
  "tags": [],
  "sources": [],
  "notes": [
    "Short float 20.72% on a ~$604M cap with 14.93M shares out. Squeeze fuel is real but liquidity is thin — volume collapsed to five figures on 2026-07-13. Size for slippage.",
    "Dividend $0.70/qtr ($2.80/yr, ~6.9-7.2%) is NOT covered: FY26 adj-EPS guide $2.30-$2.70, GAAP net income -$39.08M. Ex-date 2026-07-17 passed. Cut risk is a September call item.",
    "Consensus PT $40.00 vs $40.43 close (2026-07-17) — zero sell-side headroom. Truist cut $43→$40 in July; aggregate rating Reduce/Hold across 7 analysts.",
    "Q2 FY26 guide: revenue $380-400M, adj EPS $1.20-1.40. FY26: sales $1.475-1.505B, adj EPS $2.30-2.70. Guide assumes 10% tariff rate persists.",
    "Brand split as of Q1 FY26: Tommy Bahama $224.6M (+3.9% YoY, mid-single-digit positive comps) is fixed; Lilly Pulitzer rolled over on e-commerce + merchandising, no stated fix timeline.",
    "Q2 FY26 earnings ~2026-09-09/10 est. (FY25 analogue: announced 2025-08-02 for a 2025-09-10 release). Do not chase pre-print.",
    "Regime filter: XRT below its 40-week MA = stand aside on single-name reversal attempts in discretionary apparel. Read-across names PVH/RL/CPRI report ahead and set tone.",
    "NEVER average down here. Trailing EPS -$2.63, revenue -2.3% TTM. The bull leg is a one-time cash recovery, not an operating inflection — it does not justify adding into weakness."
  ],
  "body_markdown": "\nthough# OXM — Oxford Industries, Inc.\n\n## Current Thesis\nThree weeks ago this was a broken post-print chart with no reason to look at it. The setup has changed, and the reason is not operational. On the 2026-06-10 Q1 FY26 call management disclosed that roughly $45M of tariffs paid — about $40M across fiscal 2025 plus $5M in Q1 FY26 — were invalidated by the Supreme Court's 2026-02-20 IEEPA decision, that approximately $25M of Phase 1 refund claims are already filed, and that cash has begun arriving. None of it sits in the FY26 guide. Against a ~$604M market cap, the filed tranche alone is a little over 4% of the equity, earmarked for debt paydown, with the unfiled Phase 2 balance still outstanding. Price followed: $35.83 on 2026-06-26 to $40.43 at the 2026-07-17 close, back above both the 50-day ($39.94) and 200-day ($39.11) averages, +10.65% month-to-date and +18.22% year-to-date. Short interest sits at 20.72% of float on a $600M name. What is on offer is a balance-sheet recovery in a crowded short with the chart repaired — a special-situation leg, and not the accelerating consumer narrative the prior write-up was waiting for. Revenue is still shrinking (TTM $1.48B, −2.3%), trailing EPS is −$2.63, and consensus price target of $40.00 sits exactly where the stock trades.\n\n## Bull Case\n- **Refund cash is filed and moving**: ~$25M of Phase 1 IEEPA claims filed and partially received as of the 2026-06-10 call, versus ~$45M of invalidated duties paid ($40M FY25 + $5M Q1 FY26). Proceeds go to debt repayment, and the FY26 guide explicitly excludes them.\n- **The flagship comped positive**: Tommy Bahama sales $224.6M in Q1, +3.9% YoY, with mid-single-digit positive brand comps — the line that carried the entire bear case through FY25 turned.\n- **Gross margin absorbed the tariff without breaking**: The $11M YoY tariff headwind was offset by sourcing changes, pricing architecture and freight, per the 2026-06-10 call. The FY26 adjusted-EPS floor was raised to $2.30–$2.70 from $2.10–$2.70.\n- **Insider bought the gap**: Form 4 shows CEO Thomas C.\n- **Crowded short into a repaired chart**: 20.72% short float against a $604M cap, with price now above the 50-day and 200-day. A Phase 2 refund headline into that positioning is the asymmetric outcome.\n\n## Bear Case\n- **Sell-side sees zero upside**: Consensus price target $40.00 versus a $40.43 close on 2026-07-17 — the stock is at the target. Truist cut $43 to $40 in July; the aggregate rating reads Reduce/Hold across seven covering analysts.\n- **Demand is genuinely soft**: Management's framing on the Q1 call was that consumer caution affects \"fundamentally everything we sell.\" Revenue is −2.3% TTM and Q2 guidance of $380–400M implies flat-to-down again.\n- **The dividend is not covered**: $2.80 annual against a $2.30–$2.70 adjusted-EPS guide and GAAP net income of −$39.08M. The ~7% yield prices a cut, and the ex-date of 2026-07-17 has already passed — the next payout decision is a live risk item at the Q2 call.\n- **Refunds are non-recurring and non-operating**: A one-time cash inflow paid down against debt does not change unit economics. Guidance assumes a 10% tariff rate persists for the balance of FY26; the structural cost is still in the run-rate.\n- **Lilly Pulitzer is the open wound**: E-commerce decline and merchandising misses cited on 2026-06-10, with no stated fix timeline. The brand that cushioned FY25 is now the drag.\n- **Liquidity is thin**: 14.93M shares outstanding and daily volume that collapsed to five figures on 2026-07-13. Slippage on both entry and exit is real at size.\n\n## Setup & Price Structure\nPrice at $40.43 on the 2026-07-17 close, which was ex-dividend day (−1.68%, roughly the $0.70 distribution). The 52-week range is $30.57–$51.61, so the stock sits at the 43rd percentile of its own year. The June breakdown from $44.12 (2026-06-05) to $35.83 (2026-06-26) was a ~19% air pocket; the July recovery has retraced most of it and reclaimed the 200-day at $39.11 and the 50-day at $39.94, with the 50-day flattening rather than rolling. The shelf that matters is the $38 area — the base built in the first week of July before the refund story propagated. Above that, the structure is intact and the next resistance is the $44 pre-print gap. Forward P/E of 13.4 on the ~$2.50 adjusted midpoint is unremarkable for the group and is not the reason to be involved. There is no retail sentiment spike, no options-flow surge, and no cluster of peers breaking out alongside it — the move is idiosyncratic and cash-driven, which caps how far it runs without an operating datapoint.\n\n## Catalyst Calendar (next 30 days)\n\n- **~2026-09-09/10 (est.)** — Q2 FY26 results, outside this window. Guide is $380–400M revenue and $1.20–$1.40 adjusted EPS. This is where Lilly Pulitzer either stabilises or does not.\n\n## Elapsed catalysts\n\n- **~2026-08-01 (est.)** — Quarterly dividend payable date following the 2026-07-17 ex-date. Payment confirms no cut this quarter. *(passed 8d ago)*\n- **~2026-08-03 (est.)** — 8-K announcing the Q2 FY26 release date. The FY25 analogue landed 2025-08-02 and named 2025-09-10; expect the same shape. *(passed 6d ago)*\n- **Undated, live** — CBP establishment of the Phase 2 IEEPA refund process. Management stated on 2026-06-10 it is ready to file the remaining balance immediately. CBP has said it can process ~$127B of an estimated $166B in IEEPA duties, so the filing window and haircut are both open questions. *(passed 60d ago)*\n\n## What Would Change Our Mind\n- A weekly close below $38 breaks the July base and puts the 200-day back overhead, turning the reclaim into a failed bounce and re-opening the $35.83 low.\n- Phase 2 refund process establishment slipping past the Q2 call, or a materially smaller recovery than the ~$45M paid, removes the only quantified catalyst.\n- A dividend cut or coverage-hedging language at the September call. The payout is the reason a marginal holder owns this; removing it forces the shareholder base to turn over.\n- On the other side: Lilly Pulitzer DTC returning to flat-or-better with Tommy Bahama comps holding mid-single-digit, plus a weekly close through $44, converts this from a cash-recovery trade into an operating turn worth a larger footprint.\n\n## Correlation Notes\n- **Direct read-across**: PVH, RL and CPRI set the sector tone and report ahead on their own calendars. A discretionary-apparel group that cannot hold its own averages caps any single-name reversal here.\n- **Sector regime filter**: XRT below its 40-week average has historically been enough to abort reversal attempts in this cohort. Check it before treating the MA reclaim as durable.\n- **Tariff-refund cohort**: OXM now trades partly as a proxy for IEEPA refund recovery alongside other import-heavy small caps. Headlines from CBP or the Court of International Trade move the whole basket, independent of retail demand.\n- **Rate sensitivity**: A ~7% yielder with net debt trades against the long end. A back-up in 10-year yields compresses the dividend's relative appeal at exactly the moment refund cash is meant to be deleveraging the balance sheet.",
  "first_seen": "2026-04-20",
  "last_analyzed": "2026-07-29T06:12:21+00:00",
  "last_synthesized": "2026-07-19",
  "last_update_source": "theme_discovery",
  "license": "Content © orbyd. Cite the canonical URL."
}